Rational Design and Synthesis of a Novel Membrane Binding NaV1.8 Selective Inhibitor With in Vivo Activity in Pain Models

Biophysical Journal - United States
doi 10.1016/j.bpj.2015.11.247
Full Text
Abstract

Available in full text

Categories
Biophysics
Date
Authors
Publisher

Elsevier BV

Related search

Controlling Resistant Bacteria With a Novel Class of Β-Lactamase Inhibitor Peptides: From Rational Design to in Vivo Analyses

Scientific Reports
Multidisciplinary
2014English

TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

A Novel Actin Binding Drug With in Vivo Efficacy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Synthesis and Binding Studies of a Novel Highly Selective Ag(I) Ligand

2020English

Synthesis and Binding Studies of a Novel Highly Selective Ag(I) Ligand

2020English

Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models

International Journal of Cancer
Cancer ResearchOncology
2019English

Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 to Optimize Paralog-Selective Binding

English

Characterization of Domain-Selective Inhibitor Binding in Angiotensin-Converting Enzyme Using a Novel Derivative of Lisinopril

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2010English

Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy